ETOPOSIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for etoposide and what is the scope of patent protection?

Etoposide is the generic ingredient in four branded drugs marketed by Mylan, Strides Pharma, Accord Hlthcare, Dash Pharms, Dash Pharms Natco, Fresenius Kabi Usa, Hikma, Hospira, Meitheal, Pharmachemie Bv, Pierre Fabre, Teva Parenteral, Teva Pharms Usa, Watson Labs, Watson Labs Inc, Corden Pharma, Bristol Myers Squibb, and Cheplapharm, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for etoposide. Five suppliers are listed for this compound.

Summary for ETOPOSIDE

US Patents:	0
Tradenames:	4
Applicants:	18
NDAs:	20
Drug Master File Entries:	11
Finished Product Suppliers / Packagers:	5
Raw Ingredient (Bulk) Api Vendors:	90
Clinical Trials:	1,601
Patent Applications:	4,050
Drug Prices:	Drug price trends for ETOPOSIDE
What excipients (inactive ingredients) are in ETOPOSIDE?	ETOPOSIDE excipients list
DailyMed Link:	ETOPOSIDE at DailyMed

See drug prices for ETOPOSIDE

Recent Clinical Trials for ETOPOSIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Vanderbilt-Ingram Cancer Center	Phase 1/Phase 2
Genentech, Inc.	Phase 1/Phase 2
Vanderbilt-Ingram Cancer Center	Phase 2

See all ETOPOSIDE clinical trials

Pharmacology for ETOPOSIDE

Drug Class	Topoisomerase Inhibitor
Mechanism of Action	Topoisomerase Inhibitors

Medical Subject Heading (MeSH) Categories for ETOPOSIDE

Antineoplastic Agents, Phytogenic
Topoisomerase II Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for ETOPOSIDE

L01CB	Podophyllotoxin derivatives
L01C	PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01	ANTINEOPLASTIC AGENTS
L	Antineoplastic and immunomodulating agents

US Patents and Regulatory Information for ETOPOSIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	ETOPOSIDE	etoposide	INJECTABLE;INJECTION	074351-001	Aug 30, 1995		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	ETOPOSIDE	etoposide	INJECTABLE;INJECTION	074320-001	Aug 30, 1995		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Dash Pharms Natco	ETOPOSIDE	etoposide	INJECTABLE;INJECTION	203507-001	Nov 20, 2017		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma	ETOPOSIDE	etoposide	INJECTABLE;INJECTION	074290-001	Jul 17, 1995	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Strides Pharma	VEPESID	etoposide	CAPSULE;ORAL	019557-001	Dec 30, 1986		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ETOPOSIDE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Strides Pharma	VEPESID	etoposide	CAPSULE;ORAL	019557-001	Dec 30, 1986	⤷ Sign Up	⤷ Sign Up
Corden Pharma	VEPESID	etoposide	INJECTABLE;INJECTION	018768-001	Nov 10, 1983	⤷ Sign Up	⤷ Sign Up
Strides Pharma	VEPESID	etoposide	CAPSULE;ORAL	019557-002	Dec 30, 1986	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.